J1575 Medicare Reimbursement Rate (2026)
Current CMS pricing and breakdown for Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg i....
National Average Payment
Non-Facility (Private Office) Rate
J1575 Reimbursement Rate History
| Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|
| National Average Payment | $17.69 | $17.57 | $18.39 | $18.15 | $18.33 | $18.80 |
ℹ️ Good to Know
This item has a standard price nationwide. Your local rate will likely match the amount shown above.
Code Description
Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
Reimbursement Summary
CPT code J1575 (Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin) had a 2026 Medicare non-facility reimbursement rate of $18.80. This reflects a 7.05% change from the prior year.
The 2026 National Medicare reimbursement for J1575 is $18.80. This item is paid at a standard national rate, so local variation is typically minimal.
Description: Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin. Payment policies and coverage rules can still vary by setting and claim details, so confirm final guidance through CMS when needed.
J1575 Reimbursement Rate History
| Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|
| National Average Payment | $17.69 | $17.57 | $18.39 | $18.15 | $18.33 | $18.80 |
Historical Medicare Reimbursement
| Quarter | Non-Facility Rate | Facility Rate | YoY % Change (Non-Fac) | YoY % Change (Fac) |
|---|---|---|---|---|
| 2026 Q2 | $18.80 | $18.80 | +7.05% | +7.05% |
| 2026 Q1 | $18.33 | $18.33 | +3.61% | +3.61% |
| 2025 Q4 | $18.15 | $18.15 | — | — |
| 2025 Q3 | $18.39 | $18.39 | — | — |
| 2025 Q2 | $17.57 | $17.57 | — | — |
| 2025 Q1 | $17.69 | $17.69 | — | — |
Facility vs. Non-Facility (Office) Payment
Facility vs. non-facility pricing most commonly applies to physician services paid under the RVU-based Physician Fee Schedule. For J1575 (Drug / Biological), the payment methodology may not include both facility and non-facility rates.
Q2 2026 Breakdown
| Component | Office (Non-Fac) | Facility (Hosp) |
|---|---|---|
| Work RVU | ||
| Practice Expense (PE) | ||
| Malpractice (MP) | ||
| Total RVUs | 0.00 | 0.00 |
Learn How This Reimbursement Is Calculated
Medicare reimbursement is determined by RVUs, geographic adjustments, and the annual conversion factor.
Frequently Asked Questions
What is the 2026 Medicare rate for J1575?
The 2026 National Average Medicare reimbursement rate for J1575 (Drug / Biological) is $18.80. This rate is effective as of January 1, 2026.
What is the description for code J1575?
Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin
Why do facility and non-facility payments differ for J1575?
Facility vs. non-facility differences usually apply to RVU-based physician services. J1575 may not use both facility and non-facility pricing depending on its payment methodology.
How can I find my local Medicare rate for J1575?
Use MedFeeSchedule's Medicare Physician Fee Schedule Lookup Tool on the homepage to estimate your locality-adjusted reimbursement. Medicare payment can vary based on geographic adjustments (GPCI), place of service, and claim specifics.
Is J1575 covered by Medicare?
Coverage depends on medical necessity, setting, and Medicare policy. Some codes may be bundled, contractor-priced, or restricted. Verify final coverage guidance through CMS or your local MAC when applicable.
